Asymbescaline

Asymbescaline (also known as 3,4,5-trimethoxy-4-bromoamphetamine) is a psychedelic drug and a substituted amphetamine. It is structurally related to mescaline, a naturally occurring psychedelic found in certain cacti.

History

Asymbescaline was first synthesized by Alexander Shulgin, a renowned chemist and psychopharmacologist, who documented his findings in his book PiHKAL (Phenethylamines I Have Known And Loved). Shulgin's work has been instrumental in the study of psychedelic substances.

Pharmacology

Asymbescaline is a serotonin receptor agonist. It works by binding to and activating the serotonin receptors in the brain, which leads to the drug's psychedelic effects. The exact mechanism of action is still not fully understood, but it is believed to involve a complex interplay of neurotransmitters and receptors.

Effects

The effects of asymbescaline are similar to those of other psychedelics like LSD and mescaline. They include visual hallucinations, altered thought processes, and a heightened sense of empathy. The duration of effects can last up to 12 hours, depending on the dose and individual metabolism.

Legal Status

Asymbescaline is a Schedule I controlled substance in the United States, meaning it is illegal to manufacture, distribute, or possess without a license. It is also controlled under similar laws in many other countries.

See Also

• Phenethylamine
• Psychedelic drug
• Alexander Shulgin
• PiHKAL

References

• Shulgin, Alexander. PiHKAL: A Chemical Love Story. Transform Press, 1991.